CardieX Limited (CDX.AX)

0,0720 +0,0060 (+9,09%) Al cierre: 03:59PM AEST

CardieX Limited

55 Lime Street
Suite 301 Level 3
Sydney, NSW 2000
Australia
61 2 9874 8761
https://cardiex.com

Sector(es): Healthcare
Sector: Medical Devices
Empleados a tiempo completo: 

Ejecutivos clave

Nombre	Título	Paga	Ejecutado	Año de nacimiento
Mr. Niall Charles Edgar Cairns ACA, B.Ec, FAICD	Co-Founder & Executive Chairman	303,11k	N/A	1964
Mr. Craig R. Cooper BEC, L.L.B.	Co-Founder, Group CEO, MD & Executive Director	780,02k	N/A	1964
Dr. Ahmad Qasem Ph.D.	Chief Science & Research Officer	215,87k	N/A	1964
Dr. Steven Kesten	Chief Medical Officer	201,55k	N/A	1958
Dr. Mark Gorelick Ph.D.	Chief Product Officer	375,02k	N/A	1975
Ms. Catherine Liao	Chief Strategy Officer	359,04k	N/A	1979
Mr. Douglas T. Kurschinski	Executive VP & Head of Global Sales for AtCor Medical Division	342,61k	N/A	N/A

Los importes son a partir de 31 de diciembre de 2023 y los valores de compensación son para el último año fiscal que finaliza en esa fecha. Paga es el salario, las bonificaciones, etc. Ejecutado es el valor de las opciones ejecutadas durante el año fiscal. Divisa en AUD.

Descripción

CardieX Limited designs, manufactures, and markets medical devices used in cardiovascular health management in the Americas, Europe, and the Asia Pacific. It offers SphygmoCor, a vascular biometric technology that measures arterial health by collecting digital vascular biomarkers using novel sensors. The company also provides medical devices and vascular biomarkers for hypertension, cardiovascular disease, and other vascular health disorders; and develops and sells medical devices, digital solutions, and wearables for home health, decentralized clinical trials, and remote patient monitoring. It sells its cardiovascular devices and services to hospitals, clinics, research institutions, and pharmaceutical companies. The company was formerly known as AtCor Medical Holdings Limited and changed its name to CardieX Limited in June 2018. CardieX Limited was founded in 1994 and is based in Sydney, Australia.

Gobierno corporativo

El ISS Governance QualityScore de CardieX Limited, a día N/A, es N/A. Las puntuaciones base son Auditoría: N/A; Tablero: N/A; Derechos de los accionistas: N/A; Compensación: N/A.

Puntuación de gobierno corporativo cedida por Institutional Shareholder Services (ISS). Las puntuaciones indican un rango decil relativo al índice o región. Una puntuación decil de 1 indica un menor riesgo de gobierno, mientras que un 10 indica un riesgo de gobierno superior.